The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hematology Device Market Research Report 2025
Synopsis
Hematology instruments are machines that analyze blood. Used in medical labs, hematology instruments can do blood counts, detect proteins or enzymes, and help to diagnose illnesses or genetic defects.
The global Hematology Device market was valued at US$ 3152 million in 2023 and is anticipated to reach US$ 4766.2 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hematology Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Device.
Report Scope
The Hematology Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematology Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HORIBA
Abbott Laboratories
Siemens
Bio-Rad Laboratories
Danaher
BD
Roche
Sekisui
Axis-Shield
Chrono-Log
Sysmex Corporation
Stratec SE (Diatron),
Boule Diagnostics
Nihon Kohden
Mindray
DyMind
Urit Medical
Rayto
Segment by Type
Analyzers
Coagulation Instrument
Other
Segment by Application
Hospital/Clinics
Independent Diagnostic
Laboratories
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hematology Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hematology Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hematology instruments are machines that analyze blood. Used in medical labs, hematology instruments can do blood counts, detect proteins or enzymes, and help to diagnose illnesses or genetic defects.
The global Hematology Device market was valued at US$ 3152 million in 2023 and is anticipated to reach US$ 4766.2 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hematology Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Device.
Report Scope
The Hematology Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematology Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HORIBA
Abbott Laboratories
Siemens
Bio-Rad Laboratories
Danaher
BD
Roche
Sekisui
Axis-Shield
Chrono-Log
Sysmex Corporation
Stratec SE (Diatron),
Boule Diagnostics
Nihon Kohden
Mindray
DyMind
Urit Medical
Rayto
Segment by Type
Analyzers
Coagulation Instrument
Other
Segment by Application
Hospital/Clinics
Independent Diagnostic
Laboratories
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hematology Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hematology Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hematology Device Market Overview
1.1 Product Overview and Scope of Hematology Device
1.2 Hematology Device Segment by Type
1.2.1 Global Hematology Device Market Value Comparison by Type (2024-2030)
1.2.2 Analyzers
1.2.3 Coagulation Instrument
1.2.4 Other
1.3 Hematology Device Segment by Application
1.3.1 Global Hematology Device Market Value by Application: (2024-2030)
1.3.2 Hospital/Clinics
1.3.3 Independent Diagnostic
1.3.4 Laboratories
1.4 Global Hematology Device Market Size Estimates and Forecasts
1.4.1 Global Hematology Device Revenue 2019-2030
1.4.2 Global Hematology Device Sales 2019-2030
1.4.3 Global Hematology Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hematology Device Market Competition by Manufacturers
2.1 Global Hematology Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hematology Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hematology Device Average Price by Manufacturers (2019-2024)
2.4 Global Hematology Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hematology Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hematology Device, Product Type & Application
2.7 Hematology Device Market Competitive Situation and Trends
2.7.1 Hematology Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hematology Device Players Market Share by Revenue
2.7.3 Global Hematology Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hematology Device Retrospective Market Scenario by Region
3.1 Global Hematology Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hematology Device Global Hematology Device Sales by Region: 2019-2030
3.2.1 Global Hematology Device Sales by Region: 2019-2024
3.2.2 Global Hematology Device Sales by Region: 2025-2030
3.3 Global Hematology Device Global Hematology Device Revenue by Region: 2019-2030
3.3.1 Global Hematology Device Revenue by Region: 2019-2024
3.3.2 Global Hematology Device Revenue by Region: 2025-2030
3.4 North America Hematology Device Market Facts & Figures by Country
3.4.1 North America Hematology Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hematology Device Sales by Country (2019-2030)
3.4.3 North America Hematology Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hematology Device Market Facts & Figures by Country
3.5.1 Europe Hematology Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hematology Device Sales by Country (2019-2030)
3.5.3 Europe Hematology Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hematology Device Market Facts & Figures by Country
3.6.1 Asia Pacific Hematology Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hematology Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Hematology Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hematology Device Market Facts & Figures by Country
3.7.1 Latin America Hematology Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hematology Device Sales by Country (2019-2030)
3.7.3 Latin America Hematology Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hematology Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Hematology Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hematology Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hematology Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hematology Device Sales by Type (2019-2030)
4.1.1 Global Hematology Device Sales by Type (2019-2024)
4.1.2 Global Hematology Device Sales by Type (2025-2030)
4.1.3 Global Hematology Device Sales Market Share by Type (2019-2030)
4.2 Global Hematology Device Revenue by Type (2019-2030)
4.2.1 Global Hematology Device Revenue by Type (2019-2024)
4.2.2 Global Hematology Device Revenue by Type (2025-2030)
4.2.3 Global Hematology Device Revenue Market Share by Type (2019-2030)
4.3 Global Hematology Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hematology Device Sales by Application (2019-2030)
5.1.1 Global Hematology Device Sales by Application (2019-2024)
5.1.2 Global Hematology Device Sales by Application (2025-2030)
5.1.3 Global Hematology Device Sales Market Share by Application (2019-2030)
5.2 Global Hematology Device Revenue by Application (2019-2030)
5.2.1 Global Hematology Device Revenue by Application (2019-2024)
5.2.2 Global Hematology Device Revenue by Application (2025-2030)
5.2.3 Global Hematology Device Revenue Market Share by Application (2019-2030)
5.3 Global Hematology Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 HORIBA
6.1.1 HORIBA Corporation Information
6.1.2 HORIBA Description and Business Overview
6.1.3 HORIBA Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 HORIBA Hematology Device Product Portfolio
6.1.5 HORIBA Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Laboratories Hematology Device Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Siemens
6.3.1 Siemens Corporation Information
6.3.2 Siemens Description and Business Overview
6.3.3 Siemens Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Siemens Hematology Device Product Portfolio
6.3.5 Siemens Recent Developments/Updates
6.4 Bio-Rad Laboratories
6.4.1 Bio-Rad Laboratories Corporation Information
6.4.2 Bio-Rad Laboratories Description and Business Overview
6.4.3 Bio-Rad Laboratories Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio-Rad Laboratories Hematology Device Product Portfolio
6.4.5 Bio-Rad Laboratories Recent Developments/Updates
6.5 Danaher
6.5.1 Danaher Corporation Information
6.5.2 Danaher Description and Business Overview
6.5.3 Danaher Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Danaher Hematology Device Product Portfolio
6.5.5 Danaher Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BD Hematology Device Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Hematology Device Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Sekisui
6.8.1 Sekisui Corporation Information
6.8.2 Sekisui Description and Business Overview
6.8.3 Sekisui Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sekisui Hematology Device Product Portfolio
6.8.5 Sekisui Recent Developments/Updates
6.9 Axis-Shield
6.9.1 Axis-Shield Corporation Information
6.9.2 Axis-Shield Description and Business Overview
6.9.3 Axis-Shield Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Axis-Shield Hematology Device Product Portfolio
6.9.5 Axis-Shield Recent Developments/Updates
6.10 Chrono-Log
6.10.1 Chrono-Log Corporation Information
6.10.2 Chrono-Log Description and Business Overview
6.10.3 Chrono-Log Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chrono-Log Hematology Device Product Portfolio
6.10.5 Chrono-Log Recent Developments/Updates
6.11 Sysmex Corporation
6.11.1 Sysmex Corporation Corporation Information
6.11.2 Sysmex Corporation Hematology Device Description and Business Overview
6.11.3 Sysmex Corporation Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sysmex Corporation Hematology Device Product Portfolio
6.11.5 Sysmex Corporation Recent Developments/Updates
6.12 Stratec SE (Diatron),
6.12.1 Stratec SE (Diatron), Corporation Information
6.12.2 Stratec SE (Diatron), Hematology Device Description and Business Overview
6.12.3 Stratec SE (Diatron), Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Stratec SE (Diatron), Hematology Device Product Portfolio
6.12.5 Stratec SE (Diatron), Recent Developments/Updates
6.13 Boule Diagnostics
6.13.1 Boule Diagnostics Corporation Information
6.13.2 Boule Diagnostics Hematology Device Description and Business Overview
6.13.3 Boule Diagnostics Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Boule Diagnostics Hematology Device Product Portfolio
6.13.5 Boule Diagnostics Recent Developments/Updates
6.14 Nihon Kohden
6.14.1 Nihon Kohden Corporation Information
6.14.2 Nihon Kohden Hematology Device Description and Business Overview
6.14.3 Nihon Kohden Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nihon Kohden Hematology Device Product Portfolio
6.14.5 Nihon Kohden Recent Developments/Updates
6.15 Mindray
6.15.1 Mindray Corporation Information
6.15.2 Mindray Hematology Device Description and Business Overview
6.15.3 Mindray Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Mindray Hematology Device Product Portfolio
6.15.5 Mindray Recent Developments/Updates
6.16 DyMind
6.16.1 DyMind Corporation Information
6.16.2 DyMind Hematology Device Description and Business Overview
6.16.3 DyMind Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.16.4 DyMind Hematology Device Product Portfolio
6.16.5 DyMind Recent Developments/Updates
6.17 Urit Medical
6.17.1 Urit Medical Corporation Information
6.17.2 Urit Medical Hematology Device Description and Business Overview
6.17.3 Urit Medical Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Urit Medical Hematology Device Product Portfolio
6.17.5 Urit Medical Recent Developments/Updates
6.18 Rayto
6.18.1 Rayto Corporation Information
6.18.2 Rayto Hematology Device Description and Business Overview
6.18.3 Rayto Hematology Device Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Rayto Hematology Device Product Portfolio
6.18.5 Rayto Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hematology Device Industry Chain Analysis
7.2 Hematology Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hematology Device Production Mode & Process
7.4 Hematology Device Sales and Marketing
7.4.1 Hematology Device Sales Channels
7.4.2 Hematology Device Distributors
7.5 Hematology Device Customers
8 Hematology Device Market Dynamics
8.1 Hematology Device Industry Trends
8.2 Hematology Device Market Drivers
8.3 Hematology Device Market Challenges
8.4 Hematology Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
